Physician profile
Matthew William Gomory
NPI 1801359070
$1,914.05
in general payments reported to CMS, 2019-2025
15 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,028 · 2024: $731 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.13 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,003.73 | 2023-2024 | Omnia, Senza |
| Medtronic, INC. | $302.26 | 2024-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $138.78 | 2024 | Intracept |
| Nalu Medical, INC. | $136.18 | 2023 | Nalu Neurostimulation System |
| Mimedx Group, INC. | $122.29 | 2024 | |
| Dexcom, INC. | $34.16 | 2024 | Dexcom G6 Transmitter |
| Avanos Medical | $28.44 | 2025 | Generator |
| Globus Medical, INC. | $27.06 | 2025 | Senza |
| Tandem Diabetes Care, INC. | $24.82 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $23.18 | 2024 | Prolia, Evenity |
| Almatica Pharma LLC | $19.19 | 2025 | Teriparatide |
| Recordati_rare_diseases_inc. | $17.55 | 2024 | Isturisa, Signifor Lar |
| Abbott Laboratories | $14.59 | 2025 | Eterna |
| Lilly USA, LLC | $13.89 | 2025 | Zepbound |
| Beta Bionics, INC. | $7.93 | 2024 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gomory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.